MILabs
Heidelberglaan 100 STR 4.105
Utrecht
NL 3584 CX
Tel: 31-88-756-5343
Fax: 31-88-756-0094
Website: http://www.milabs.com/
Email: info@milabs.com
About MILabs
MILabs B.V. (Utrecht, the Netherlands) provides high-end molecular imaging solutions for biomedical and pharmaceutical research. Today these systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases. As documented in over hundreds of scientific articles, U-SPECT provides the fastest, most sensitive and highest resolution small-animal SPECT system currently available. Recently MILabs fused state-of-the-art Adaptive PET with its SPECT technology by introducing VECTor/CT. This versatile nuclear imaging system is an extremely powerful non-invasive imaging system for small animals since it enables simultaneous sub-mm resolution PET/SPECT acquisitions of co-injected PET and SPECT tracers. Moreover, the VECTor platform offers the extreme flexibility of accommodating additional high-resolution, low-dose X-ray CT and Hybrid Optical luminescence and fluorescence imaging capabilities. For more information, visit www.milabs.com.YEAR FOUNDED:
2006
LEADERSHIP:
Founder and CEO: Frederik Beekman
JOBS:
Please click here for MILabs job opportunities.
FOLLOW MILABS:
Tweets by MILabs
15 articles about MILabs
-
MILabs’ VECTor6 with groundbreaking PET performance awarded Innovation of the Year at the WMIC 2018
9/18/2018
MILabs is pleased to announce that its new VECTor6 with Broadband Photon Tomography technique has received the Commercial Innovation Award at the World Molecular Imaging Congress (WMIC) in Seattle September 12th-15th, 2018.
-
MILabs Broadband Photon Tomography nominated for Innovation of the Year - WMIC 2018
9/4/2018
MILabs is pleased to announce that its new Broadband Photon Tomography technique has been nominated for the Innovation of the Year 2018 award by the World Molecular Imaging Society (WMIS) board of trustees.
-
University of Sydney acquires state-of-the-art MILabs preclinical in-vivo X-ray CT
8/31/2018
MILabs announces that is has successfully completed the installation of its next-generation Adaptive U-CTXUHR at Sydney Imaging, a Core Research Facility of the University of Sydney.
-
The Hebrew University of Jerusalem installs MILabs’ dual-energy, ultra-high resolution microCT
7/30/2018
A MILabs dual-energy, ultra-high resolution U-CT system has been installed at the Hebrew University of Jerusalem Israel (HUJI). Under the direction of Professor Galia Blum, this institute has established an internationally renowned research program, focused on drug design, delivery, and therapy.
-
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26, MILabs announced innovative new PET features.
-
Advances in data storage and processing, as well as biomarker identification, has led to cutting-edge breakthroughs in clinical and research imaging technology. Here’s a look at just a few of these stories.
-
Technical University Munich installs MILabs’ PET/SPECT/Optical/CT for translational imaging
5/30/2018
A MILabs VECTor5PET/SPECT/OI/CT system has been installed at the Chair of Pharmaceutical Radiochemistry on the TUM Campus in Garching.
-
MILabs installs new VECTor5CT at Italian’s prestigious Veneto Institute of Oncology
4/25/2018
The Istituto Oncologico Veneto (IOV) has acquired MILabs’ latest generation VECTor5CT as a key imaging tool to support its translational oncology mission, entrusted by the Italian Ministry of Health and the Organization of the European Cancer Institutes.
-
University of Copenhagen Installs Latest MILabs VECTor5CT System to Further Accelerate Neuroscience Research.
2/5/2018
MILabs announced today that it has successfully completed the installation of its top-of-the-line multimodality PET-SPECT-UHR CT in the laboratory of Prof. Maiken Nedergaard, M.D, D.M.Sci. - Center for Translational Neuroscience, Division of Glial Disease and Therapeutics.
-
MILabs Installs First Fully Integrated PET/SPECT/OI/CT Molecular Imaging Platform At The Erasmus MC
9/27/2017
-
MILabs Continues Its Record-Setting Pace Of Preclinical Imaging Sales Into The Vacation Period
8/11/2017
-
MILabs Installs Cutting-Edge U-CT At National Yang-Ming University
6/28/2017
-
MILabs Launches New 5-Series Preclinical Imaging Platform At SNMMI 2017
6/6/2017
-
University of Alabama at Birmingham Selects MILabs Adaptive U-CT To Expand Its Pulmonary Research
11/29/2016
-
MILabs Release: Breakthrough Biomedical Imaging Technology: Automated Quantitative 3D Autoradiography
10/17/2016